Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Chuang-Stein, Christy
139  Ergebnisse:
Personensuche X
?
1

Discounting Prior Results to Account for Selection Bias:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 197-223 , 2021
Link: https://doi.org/10.1007/..
 
?
2

Designing Phase 4 Trials:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 163-176 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Characteristics of a Diagnostic Test:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 39-46 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Designing Dose–Response Studies with Desired Characteristic:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 127-146 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Designing Proof-of-Concept Trials with Desired Characterist..:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 99-126 , 2021
Link: https://doi.org/10.1007/..
 
?
6

Other Metrics That Have Been Proposed to Optimize Drug Deve..:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 177-196 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Choosing Metrics Appropriate for Different Stages of Drug D..:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 81-97 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Adaptive Designs:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 225-251 , 2021
Link: https://doi.org/10.1007/..
 
?
9

The Parallel Between Clinical Trials and Diagnostic Tests:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 47-58 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Clinical Testing of a New Drug:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 1-21 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Incorporating Information from Completed Trials and Other S..:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 59-79 , 2021
Link: https://doi.org/10.1007/..
 
?
12

p-Values and Replicability: A Commentary on "The Role of p-..:

Chuang-Stein, Christy ; Kirby, Simon
Statistics in Biopharmaceutical Research.  13 (2021)  1 - p. 36-39 , 2021
Link: https://doi.org/10.1080/..
 
?
13

Additional Topics:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 253-271 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Designing Confirmatory Trials with Desired Characteristics:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 147-162 , 2021
Link: https://doi.org/10.1007/..
 
?
15

A Frequentist Decision-Making Framework:

, In: Quantitative Decisions in Drug Development; Springer Series in Pharmaceutical Statistics,
Chuang-Stein, Christy ; Kirby, Simon - p. 23-38 , 2021
Link: https://doi.org/10.1007/..
 
1-15